Stem Cell Therapy and Autism

What is Autism?

When people talk about “Autism”, they usually mean Autism Spectrum Disorders (ASD) which is caused by a brain-based disorder. Autism is characterized by social communication challenges and restricted repetitive behavior, interests, and activities. According to the center for disease control, ASDs are described as “a developmental disability that can cause significant social, communication, and behavioral challenges.”

What is the scientific rationale behind using stem cells to treat autism?

Despite recent autism therapies and investigations in an attempt to reverse these brain abnormalities through administering antibiotics, hyperbaric oxygen, and anti-inflammation. Yet, none of these techniques and approaches are able to address the root cause of oxygen deprivation and intestinal inflammations.

However, the reason behind treating Autism Spectrum Disorders (ASDs) with umbilical cord tissues derived from mesenchymal stem cells is that autism and its rate of severity have been known to have a significant relationship with Neuro-inflammatory and inflammatory cytokines, which includes thymus, macrophage-derived chemokine (MDC), and activation-regulated chemokine (TARC). The intravenous administration of umbilical cords MSCs has been proven in multiple clinical trials to have successfully decreased inflammation effectively. By decreasing inflammation in an autism patient, symptoms of autism have shown to be alleviated.

Through the administration of mesenchymal stem cells, we have recorded successful improvements in autism patients being treated in our facilities.